393 Results

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Shouval
    Shouval
  4. Shah
    Shah
  5. Nelson
    Nelson
  6. Park
    Park
  7. Scordo
    Scordo
  8. Dahi
    Dahi
  9. Jones
    Jones
  10. Mehrara
    Mehrara

Groups

  1. Department of Medicine (175)
  2. Surgery (101)
  3. Survivorship Research (98)
  4. Hematologic Malignancies, Division of (92)
  5. Center for Hematologic Malignancies (78)
  6. Sloan Kettering Institute Postdocs (66)
  7. Solid Tumor Oncology Division (66)
  8. Population Sciences Research Program (60)
  9. Division of Subspecialty Medicine (57)
  10. Epidemiology and Biostatistics (57)
  1. "adverse event"
Formats
  1. Journal Article (266)
  2. Review (75)
  3. Editorial (17)
  4. Guidelines (11)
  5. Research Letter (11)
  6. Correspondence (8)
  7. Conference Paper (2)
  8. Miscellaneous (2)
  9. Meeting Abstract (1)
Groups
  1. Department of Medicine (175)
  2. Surgery (101)
  3. Survivorship Research (98)
  4. Hematologic Malignancies, Division of (92)
  5. Center for Hematologic Malignancies (78)
  6. Sloan Kettering Institute Postdocs (66)

More Groups

People
  1. Miguel-Angel Perales (32)
  2. Sergio Giralt (20)
  3. Sean Devlin (17)
  4. Jonas Nelson (14)
  5. Roni Shouval (13)
  6. Gunjan Shah (12)

More People

Years
  1. 2025 (62)
  2. 2024 (100)
  3. 2023 (62)
  4. 2022 (106)
  5. 2021 (15)
  6. 2020 (17)

More Years

Publications
  1. Transplantation and Cellular Therapy (26)
  2. Journal of Clinical Oncology (17)
  3. Clinical Cancer Research (11)
  4. International Journal of Radiation Oncology, Biology, Physics (11)
  5. Annals of Surgical Oncology (10)
  6. Plastic and Reconstructive Surgery (10)

More Publications

Publishers
  1. Elsevier Inc. (76)
  2. Springer (39)
  3. Elsevier Science, Inc. (34)
  4. Nature Publishing Group (25)
  5. Lippincott Williams & Wilkins (23)
  6. American Society of Clinical Oncology (18)

More Publishers

Results (393)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on pediatric chronic graft-versus-host disease survivorship after hematopoietic cell transplantation: Part I. Phases of chronic GVHD, supportive care, and systemic therapy discontinuation
    Journal Article

    Bhatt, N. S.; Harris, A. C.; Gorfinkel, L.; Ibanez, K.; Tkaczyk, E. R.; Mitchell, S. A.; Albuquerque, S.; Schechter, T.; Pavletic, S.; Duncan, C. N.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Outcomes after brexucabtagene autoleucel administered as a standard therapy for adults with relapsed/refractory B-cell ALL
    Journal Article

    Roloff, G. W.; Aldoss, I.; Kopmar, N. E.; Lin, C.; Dekker, S. E.; Gupta, V. K.; O’Connor, T. E.; Jeyakumar, N.; Muhsen, I. N.; Valtis, Y.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Global metabolomic alterations associated with endocrine-disrupting chemicals among pregnant individuals and newborns
    Journal Article

    Puvvula, J.; Song, L. C.; Zalewska, K. J.; Alexander, A.; Manz, K. E.; Braun, J. M.; Pennell, K. D.; DeFranco, E. A.; Ho, S. M.; Leung, Y. K.; more...
    Metabolomics (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Safety and tolerability of letetresgene autoleucel (GSK3377794): Pilot studies in patients with advanced non–small cell lung cancer
    Journal Article

    Altan, M.; Lopes, G.; Hiltermann, T. N. J.; Govindan, R.; Villaruz, L. C.; Calvo, E.; Edelman, M. J.; Furqan, M.; Neal, J.; Felip, E.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Fueling metabolic disruption via FMD to boost chemotherapy in TNBC
    Editorial

    Goncalves, M. D.; Iyengar, N. M.
    Cell Metabolism (2025)

    Fulltext@MSK | Save
  • Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3–targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer
    Review

    Sands, J. M.; Champiat, S.; Hummel, H. D.; Paulson, K. G.; Borghaei, H.; Alvarez, J. B.; Carbone, D. P.; Carlisle, J. W.; Choudhury, N. J.; Clarke, J. M.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: Results from a large retrospective cohort
    Journal Article

    Melica, G.; Luna de Abia, A.; Shah, G. L.; Devlin, S.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Palomba, M. L.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): A single-arm, open-label, phase 1, dose-escalation study
    Journal Article

    Iyer, S. P.; Sica, R. A.; Ho, P. J.; Prica, A.; Zain, J.; Foss, F. M.; Hu, B.; Beitinjaneh, A.; Weng, W. K.; Kim, Y. H.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Clinical presentations of skin of color in oncodermatology
    Journal Article

    Chen, A.; Lavin, L.; Markova, A.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2025)

    Fulltext@MSK | Save